Metabolon Expands Biomarker Collaboration with Mitsubishi Tanabe | GenomeWeb
NEW YORK (GenomeWeb News) – Metabolon said today that it has expanded its ongoing biomarker discovery collaboration with Mitsubishi Tanabe Pharma.
Research Triangle Park, NC-based Metabolon said that the new agreement will provide researchers at the Japanese firm with preferred access to Metabolon’s global biochemical profiling services. It also said that Mitsubishi Tanabe has committed several upcoming research studies to Metabolon.
Further terms of the alliance were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.